PPD and Shin Nippon Biomedical Laboratories Ltd. have entered an agreement to form a joint venture (PPD-SNBL) that will provide a full range of clinical development services in Japan, including Phase I-IV clinical trial monitoring, project management, site intelligence and activation, biostatistics, data management, medical writing, pharmacovigilance, regulatory and FSP services.   PPD-SNBL will combine SNBL’s clinical research division and PPD’s clinical development operations in Japan, and it ...